Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis.

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease with significant extra-articular manifestations.
• Cardiovascular (CV) disease is a leading cause of mortality in RA patients, exceeding general population rates.
• Traditional CV risk factors are more prevalent in RA, but do not fully explain the elevated CV event incidence.

Purpose of the Study:

• To review cardiovascular disease risk factors in rheumatoid arthritis.
• To explore the role of systemic inflammation and dyslipidemia in RA-associated atherosclerosis.
• To discuss the impact of early anti-inflammatory therapeutic interventions on CV outcomes in RA.

Main Methods:

• This is a review article, synthesizing existing research on RA and cardiovascular disease.
• The review examines literature on traditional CV risk factors, comorbidities, and systemic inflammation in RA.
• It specifically addresses dyslipidemia, the lipid paradox, and inflammatory mechanisms driving atherosclerosis in RA patients.

Main Results:

• Systemic inflammation, characterized by proinflammatory cytokines and acute phase reactants, significantly contributes to premature atherosclerosis in RA.
• While traditional risk factors are common, they are insufficient to account for the high CV event rates in RA.
• The 'lipid paradox' in RA, where lipid levels may not reflect CV risk accurately, is highlighted.

Conclusions:

• Systemic inflammation is a key driver of accelerated atherosclerosis and increased CV risk in rheumatoid arthritis.
• Early and effective suppression of inflammation through therapeutic intervention is crucial for mitigating CV disease in RA patients.
• Addressing both traditional risk factors and systemic inflammation is essential for comprehensive CV risk management in RA.